Literature DB >> 11573052

Fibrinogen, lipoprotein (a) and lipids in patients with erectile dysfunction. A preliminary study.

M E Sullivan1, M A Miller, C R Bell, I A Jagroop, C S Thompson, M A Khan, R J Morgan, D P Mikhailidis.   

Abstract

BACKGROUND: Erectile dysfunction is associated with cardiovascular risk factors (e.g. hypertension, smoking, dyslipidemia and diabetes) and is more common in patients with cardiovascular disease. We therefore assessed the prevalence of two predictors of vascular events, fibrinogen and lipoprotein-a, in patients with and without erectile dysfunction.
METHODS: Men with erectile dysfunction (48 non-smokers, 48 smokers), aged 45-70 years, were compared with controls (21 non-smokers, 21 smokers) with normal erectile function and no known pathology.
RESULTS: Serum total cholesterol was significantly higher in non-smokers with erectile dysfunction compared to both control non-smokers and erectile dysfunction smokers. Men with erectile dysfunction who smoked had a significantly higher plasma fibrinogen level than control smokers. Similarly, men with erectile dysfunction, who did not smoke had higher levels of plasma fibrinogen compared to both smokers and non-smokers without erectile dysfunction. No significant difference in serum lipoprotein-a values was found.
CONCLUSIONS: These findings support the concept that cardiovascular risk factors are predictors of erectile dysfunction and that this may be another manifestation of vascular disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11573052

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  5 in total

Review 1.  Emerging role for TNF-α in erectile dysfunction.

Authors:  Fernando S Carneiro; Robert Clinton Webb; Rita C Tostes
Journal:  J Sex Med       Date:  2010-12       Impact factor: 3.802

2.  Association Between Erectile Function and Biomarkers of Subclinical Atherosclerosis: A Study Based on Middle-Aged Healthy Men from the General Population.

Authors:  Saad Elzanaty; Babak Rezanezhad; Ronnie Willenheimer; Rasmus Borgquist
Journal:  Curr Urol       Date:  2016-09-20

Review 3.  Erectile dysfunction: expectations beyond phosphodiesterase type 5 inhibition.

Authors:  A Aversa; M Pili; A Fabbri; E Spera; G Spera
Journal:  J Endocrinol Invest       Date:  2004-02       Impact factor: 4.256

4.  Effects of renal transplantation on erectile dysfunction: a systematic review and meta-analysis.

Authors:  Irham Arif Rahman; Nur Rasyid; Ponco Birowo; Widi Atmoko
Journal:  Int J Impot Res       Date:  2021-06-08       Impact factor: 2.408

5.  Mechanism of endothelial cyto-protective and thrombo-resistance effects of sildenafil, vardenafil and tadalafil in male rabbit.

Authors:  Mohamed-I Kotb El-Sayed; Hatem Al-Kordy A Amin
Journal:  Arch Med Sci       Date:  2013-03-05       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.